Clinical Trials Browser

Craniopharyngioma × tocilizumab × 90 days × Clear all

NCT05233397 2026-04-23

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

Craniopharyngioma